MiR-150 impairs inflammatory cytokine production by targeting ARRB-2 after blocking CD28/B7 costimulatory pathway
- 5 November 2015
- journal article
- Published by Elsevier BV in Immunology Letters
- Vol. 172, 1-10
- https://doi.org/10.1016/j.imlet.2015.11.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA 94872)
- National Natural Science Foundation of China (08144110)
- Natural Science Foundation of Jiangsu Province (BK2012572)
- Natural Science Fund of Higher Education of Jiangsu Province (14KJB320024)
This publication has 50 references indexed in Scilit:
- An In Vivo Functional Screen Uncovers miR-150-Mediated Regulation of Hematopoietic Injury ResponseCell Reports, 2012
- MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cellsCarcinogenesis: Integrative Cancer Research, 2011
- The widespread regulation of microRNA biogenesis, function and decayNature Reviews Genetics, 2010
- Cross Talk between Phosphatidylinositol 3-Kinase and Cyclic AMP (cAMP)-Protein Kinase A Signaling Pathways at the Level of a Protein Kinase B/β-Arrestin/cAMP Phosphodiesterase 4 ComplexMolecular and Cellular Biology, 2010
- MicroRNA control of signal transductionNature Reviews Molecular Cell Biology, 2010
- microRNAs and the immune responseCurrent Opinion in Pharmacology, 2009
- Physiological and pharmacological implications of beta-arrestin regulationPharmacology & Therapeutics, 2008
- c-Myb Is an Evolutionary Conserved miR-150 Target and miR-150/c-Myb Interaction Is Important for Embryonic DevelopmentMolecular Biology and Evolution, 2008
- miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurelyProceedings of the National Academy of Sciences, 2007
- Signal transduction by lymphocyte antigen receptorsCell, 1994